Skip to content
10-Q

Quarterly Report

Sigilon Therapeutics, Inc.

0001558370-23-013494

← back to feed
Filed
Aug 7, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 1, 2023 2.51M sh
Shares Diluted Q2 2023 · Jun 30, 2023 2.5M sh
Shares Diluted Q2 2023 · Jun 30, 2023 2.5M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 2.49M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 2.49M sh
Capex Q2 2023 · Jun 30, 2023 $490K
Capex Q2 2023 · Jun 30, 2022 $506K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$15.56M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$34.27M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $19.62M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $42.07M
Stockholders Equity Q2 2023 · Jun 30, 2023 $27.45M
Stockholders Equity Q2 2023 · Mar 31, 2023 $33.29M
Stockholders Equity Q2 2023 · Dec 31, 2022 $39.14M
Stockholders Equity Q2 2023 · Jun 30, 2022 $51.81M
Stockholders Equity Q2 2023 · Mar 31, 2022 $64.59M
Stockholders Equity Q2 2023 · Dec 31, 2021 $77.16M
Current Liabilities Q2 2023 · Jun 30, 2023 $25.25M
Current Liabilities Q2 2023 · Dec 31, 2022 $30.99M
Total Liabilities Q2 2023 · Jun 30, 2023 $28.11M
Total Liabilities Q2 2023 · Dec 31, 2022 $48.14M
Current Assets Q2 2023 · Jun 30, 2023 $44.87M
Current Assets Q2 2023 · Dec 31, 2022 $74.41M
Total Assets Q2 2023 · Jun 30, 2023 $55.56M
Total Assets Q2 2023 · Dec 31, 2022 $87.28M
Eps Diluted Q2 2023 · Jun 30, 2023 −$3.00
Eps Diluted Q2 2023 · Jun 30, 2023 −$5.95
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$5.76
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$11.32
Eps Basic Q2 2023 · Jun 30, 2023 −$3.00
Eps Basic Q2 2023 · Jun 30, 2023 −$5.95
Eps Basic restated Q2 2023 · Jun 30, 2022 −$5.76
Eps Basic restated Q2 2023 · Jun 30, 2022 −$11.32
Sga Expense Q2 2023 · Jun 30, 2023 $5.88M
Sga Expense Q2 2023 · Jun 30, 2023 $10.21M
Sga Expense Q2 2023 · Jun 30, 2022 $5.04M
Sga Expense Q2 2023 · Jun 30, 2022 $10.07M
Rd Expense Q2 2023 · Jun 30, 2023 $7.45M
Rd Expense Q2 2023 · Jun 30, 2023 $15.23M
Rd Expense Q2 2023 · Jun 30, 2022 $11.88M
Rd Expense Q2 2023 · Jun 30, 2022 $23.5M
Net Income Q2 2023 · Jun 30, 2023 −$7.51M
Net Income Q2 2023 · Jun 30, 2023 −$14.88M
Net Income Q2 2023 · Mar 31, 2023 −$7.38M
Net Income Q2 2023 · Dec 31, 2022 −$43.6M
Net Income Q2 2023 · Jun 30, 2022 −$14.35M
Net Income Q2 2023 · Jun 30, 2022 −$28.21M
Net Income Q2 2023 · Mar 31, 2022 −$13.86M
Operating Income Q2 2023 · Jun 30, 2023 −$7.44M
Operating Income Q2 2023 · Jun 30, 2023 −$14.68M
Operating Income Q2 2023 · Jun 30, 2022 −$14.04M
Operating Income Q2 2023 · Jun 30, 2022 −$27.51M
Revenue Q2 2023 · Jun 30, 2023 $5.9M
Revenue Q2 2023 · Jun 30, 2023 $10.76M
Revenue Q2 2023 · Jun 30, 2022 $2.88M
Revenue Q2 2023 · Jun 30, 2022 $6.05M
Long Term Debt Q2 2023 · Dec 31, 2022 $12.02M
Short Term Debt Q2 2023 · Dec 31, 2022 $6.67M